<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur J Pediatr</journal-id><journal-id journal-id-type="iso-abbrev">Eur J Pediatr</journal-id><journal-id journal-id-type="pmc-domain-id">365</journal-id><journal-id journal-id-type="pmc-domain">springeropen</journal-id><journal-title-group><journal-title>European Journal of Pediatrics</journal-title></journal-title-group><issn pub-type="ppub">0340-6199</issn><issn pub-type="epub">1432-1076</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Springer</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12474585</article-id><article-id pub-id-type="pmcid-ver">PMC12474585.1</article-id><article-id pub-id-type="pmcaid">12474585</article-id><article-id pub-id-type="pmcaiid">12474585</article-id><article-id pub-id-type="pmid">41003728</article-id><article-id pub-id-type="doi">10.1007/s00431-025-06485-y</article-id><article-id pub-id-type="publisher-id">6485</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Diagnosis of patent ductus arteriosus by different echocardiographic methods in very preterm infants</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Dani</surname><given-names initials="C">Carlo</given-names></name><address><email>carlo.dani@unifi.It</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sarcina</surname><given-names initials="D">Davide</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Corsini</surname><given-names initials="I">Iuri</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pratesi</surname><given-names initials="S">Simone</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Poggi</surname><given-names initials="C">Chiara</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Montano</surname><given-names initials="S">Simona</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Loi</surname><given-names initials="B">Barbara</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Regiroli</surname><given-names initials="G">Giulia</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>De Luca</surname><given-names initials="D">Daniele</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04jr1s763</institution-id><institution-id institution-id-type="GRID">grid.8404.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 1757 2304</institution-id><institution>Department of Neurosciences, Psychology, Drug Research and Child Health, </institution><institution>University of Florence, </institution></institution-wrap>Florence, Italy </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02crev113</institution-id><institution-id institution-id-type="GRID">grid.24704.35</institution-id><institution-id institution-id-type="ISNI">0000 0004 1759 9494</institution-id><institution>Division of Neonatology, </institution><institution>Careggi University Hospital of Florence, </institution></institution-wrap>Largo Brambilla 3, Florence, 50134 Italy </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03xjwb503</institution-id><institution-id institution-id-type="GRID">grid.460789.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 4910 6535</institution-id><institution>Division of Pediatrics and Neonatal Critical Care, A. B&#233;cl&#232;re Medical Center, </institution><institution>Paris Saclay University Hospitals, </institution></institution-wrap>Paris, France </aff></contrib-group><author-notes><fn fn-type="com"><p>Communicated by Peter de Winter</p></fn></author-notes><pub-date pub-type="epub"><day>26</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>184</volume><issue>10</issue><issue-id pub-id-type="pmc-issue-id">497685</issue-id><elocation-id>639</elocation-id><history><date date-type="received"><day>19</day><month>6</month><year>2025</year></date><date date-type="rev-recd"><day>25</day><month>8</month><year>2025</year></date><date date-type="accepted"><day>14</day><month>9</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>26</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>28</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-28 13:25:37.627"><day>28</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="431_2025_Article_6485.pdf"/><abstract id="Abs2"><p id="Par1">There is no consensus regarding the timing and diagnostic criteria for identifying hemodynamically significant patent ductus arteriosus (hsPDA). Our aim was to evaluate&#160;if the use of different diagnostic criteria at different times could be associated with a different incidence of hsPDA in very preterm infants. We studied 41 infants with gestational age&#8201;&lt;&#8201;32&#160;weeks born in neonatal intensive care units (NICU) in Florence, Italy, or in Paris, France. They received the first echocardiography between 24 and 48&#160;h of life and the second between 72 and 84&#160;h to diagnose hsPDA using Florence and Paris criteria and PDA severity score. Concordance of diagnosis between criteria was evaluated with the Cohen unweighted &#954; statistic. The incidence of hsPDA diagnosed by the Florence (35%) or Paris (34%) criteria or by PDA severity score (35%) was similar. Concordance was substantial between Florence and Paris criteria and between Florence criteria and PDA severity score but was fair between Paris criteria and PDA severity score. Moreover, concordance significantly changed from the first to the second echocardiography.</p><p id="Par2">
<italic toggle="yes">Conclusion</italic>:&#160;The studied diagnostic criteria showed important variations of concordance when applied at different times. This led to diagnose hsPDA in different patients at different times while leaving the overall percentage of hsPDA unchanged. Our results suggest that more attention should be paid to the choice of diagnostic criteria for individuating hsPDA in very preterm infants.&#160;
<table-wrap id="Taba" position="float" orientation="portrait"><table frame="hsides" rules="groups"><tbody><tr><td align="left" colspan="2" rowspan="1"><p><bold>What is Known:</bold></p><p><italic toggle="yes">&#8226; There is no consensus regarding the timing and diagnostic criteria for individuating hemodynamically significant patent ductus arteriosus (hsPDA) in preterm infant.</italic></p><p><italic toggle="yes">&#8226; This implies large variations in its frequency and management diagnosis between centers.</italic></p><p><bold>What is New:</bold></p><p><italic toggle="yes">&#8226; This study evaluated for the first time how different diagnostic criteria used at different postnatal times may influence the diagnosis of hsPDA in very preterm infants.</italic></p></td></tr></tbody></table></table-wrap></p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Patent ductus arteriosus</kwd><kwd>Diagnosis</kwd><kwd>Echocardiography</kwd><kwd>Preterm infant</kwd></kwd-group><funding-group><award-group><funding-source><institution>Universit&#224; degli Studi di Firenze</institution></funding-source></award-group><open-access><p>Open access funding provided by Universit&#224; degli Studi di Firenze within the CRUI-CARE Agreement.</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer-Verlag GmbH Germany, part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par8">Patent ductus arteriosus (PDA) is a frequent complication in preterm infants with respiratory distress syndrome (RDS). Approximately 10% of infants born between 30 and 37&#160;weeks of gestation have a patent ductus at 4&#160;days after birth, but the frequency increases to 80% in those born between 25 and 28&#160;weeks and to over 90% in those born at 24&#160;weeks [<xref ref-type="bibr" rid="CR1">1</xref>]. The Vermont Oxford Network reported that in 2024, 31% of infants born at less than 30&#160;weeks&#8217; gestational age received pharmacological treatment for PDA, and 3% underwent surgical closure [<xref ref-type="bibr" rid="CR2">2</xref>]. How PDA should be managed is a subject of lively debate because randomized controlled trials of PDA closure using non-steroidal anti-inflammatory drugs failed to demonstrate significant benefits in preterm infants [<xref ref-type="bibr" rid="CR3">3</xref>] often due to study design limitations [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. However, a persistent left-to-right shunt through the ductus arteriosus (DA) complicating RDS has been associated with a worsening of respiratory failure, lowering of the survival rate, increased risk of bronchopulmonary dysplasia (BPD), pulmonary hypertension associated with BPD, and impairment of neurodevelopment [<xref ref-type="bibr" rid="CR6">6</xref>&#8211;<xref ref-type="bibr" rid="CR9">9</xref>].&#160;</p><p id="Par9">The current treatment of PDA consists of two steps: the first is pharmacological treatment and the second, if medical treatment fails, is surgical or trans-catheter closure, which should be avoided, if possible, due to the associated possible complications [<xref ref-type="bibr" rid="CR10">10</xref>]. Since PDA diameter alone demonstrated weak correlations with the magnitude of shunt volume through the ductus [<xref ref-type="bibr" rid="CR11">11</xref>], combinations of clinical and echocardiographic parameters have been proposed to identify hemodynamically significant PDA (hsPDA) that warrant treatment [<xref ref-type="bibr" rid="CR11">11</xref>&#8211;<xref ref-type="bibr" rid="CR13">13</xref>]. Brissaud et al. reported that 72% of 57 French neonatal intensive care units (NICU) used clinical and echocardiographic criteria to decide when to initiate PDA treatment, whereas 27.6% used only echocardiographic criteria, regardless of a patient&#8217;s clinical status. Moreover, they detailed that more than nine echocardiographic criteria were used for the diagnosis of hsPDA with different combinations&#160;[<xref ref-type="bibr" rid="CR12">12</xref>].</p><p id="Par10">Consistently, there is no consensus regarding the timing and diagnostic criteria for individuating hsPDA, and its assessment remains a challenge. This implies that there are large variations in the management of PDA [<xref ref-type="bibr" rid="CR14">14</xref>] and large differences in the frequency (20&#8211;60%) of hsPDA diagnosis between NICUs [<xref ref-type="bibr" rid="CR15">15</xref>].</p><sec id="Sec2"><title>Aim of the study</title><p id="Par11">Based on these considerations, we hypothesized that the use of different diagnostic criteria at different times could be associated with a different incidence of hsPDA in very preterm infants. To evaluate this hypothesis, we measured changes in the incidence of hsPDA observed using different diagnostic echocardiographic criteria (Paris and Florence criteria) and El-Khuffash&#8217;s PDA severity score [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>] in a cohort of very preterm infants at two different European hospitals.</p></sec></sec><sec id="Sec3"><title>Material and methods</title><sec id="Sec4"><title>Patients</title><p id="Par12">The study was carried out at the third level neonatal intensive care units (NICUs) of Careggi University Hospital, Florence, Italy, and A. B&#233;cl&#232;re Medical Center, Paris, France, after the approval of local ethics committees. Infants were included in the study after informed parental consent if they were born with gestational age&#8201;&lt;&#8201;32&#160;weeks of gestation and admitted from February to August 2024. Exclusion criteria were major congenital malformations, chromosomal disorders, inherited metabolic&#160;diseases, and death in the first 72 h of life.</p></sec><sec id="Sec5"><title>hsPDA diagnosis and treatment</title><p id="Par13">All patients underwent PDA assessment with the Florence criteria, the Paris criteria, and the PDA severity score. The diagnosis of hsPDA requiring pharmacological treatment was made in Florence by echocardiographic demonstration of a ductal left-to-right shunt, with a ductal size&#8201;&#8805;&#8201;1.4&#160;mm/kg and two or more other echocardiographic criteria, while in Paris, it was made by the combination of two echocardiographic criteria with gestational age (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>). As per local protocol, the first echocardiography was performed between 24 and 48&#160;h of life in Florence and between 72 and 84&#160;h in Paris. Therefore, patients born in Paris performed the first heart ultrasound between 24 and 48&#160;h of life to evaluate the results of the Florence criteria application and the second between 72 and 84&#160;h of life to evaluate the results of the Paris criteria. Differently, patients born in Florence performed the second ultrasound only when the first one excluded the diagnosis of hsPDA and the need for treatment.
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Diagnostic criteria for hsPDA used in Careggi University Hospital, Florence, Italy, and A. B&#233;cl&#232;re Medical Center, Paris, France</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Florence criteria</th><th align="left" colspan="2" rowspan="1">Paris criteria</th></tr><tr><th align="left" colspan="1" rowspan="1">Infants born&#8201;&lt;&#8201;32&#160;weeks of gestational age</th><th align="left" colspan="1" rowspan="1">Infants born&#8201;&lt;&#8201;28&#160;weeks of gestational age</th><th align="left" colspan="1" rowspan="1">Infants born 29-31&#160;weeks of gestational age</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1"><p>Ductal size&#8201;&#8805;&#8201;1.4&#160;mm/kg</p><p>and&#8201;&#8805;&#8201;2 of the following criteria:</p><p>&#8226; left atrium to aortic root (LA/Ao) ratio&#8201;&gt;&#8201;1.5</p><p>&#8226; pulsatile flow pattern</p><p>&#8226; reverse flow in descending aorta or superior mesenteric artery</p><p>&#8226; left ventricular output&#8201;&gt;&#8201;300&#160;ml/kg/min</p></td><td align="left" colspan="1" rowspan="1"><p><underline>&#8201;&gt;&#8201;</underline>2 of the following criteria:</p><p>&#8226; ductal size&#8201;&#8805;&#8201;1.5&#160;mm/kg or&#8201;&gt;&#8201;diameter of LPA</p><p>&#8226; atrium to aortic root (LA/Ao) ratio&#8201;&gt;&#8201;1.5</p><p>&#8226; resistance index&#8201;&gt;&#8201;0.9 in pericallosal artery</p><p>&#8226; diastolic flow in LPA&#8201;&gt;&#8201;0.2&#160;cm/sec</p></td><td align="left" colspan="1" rowspan="1"><p><underline>&#8201;&gt;&#8201;</underline>2 of the following criteria:</p><p>&#8226; ductal size&#8201;&#8805;&#8201;1.5&#160;mm/kg or&#8201;&gt;&#8201;diameter of LPA</p><p>&#8226; atrium to aortic root (LA/Ao) ratio&#8201;&gt;&#8201;1.5</p><p>&#8226; resistance index&#8201;&gt;&#8201;0.9 in pericallosal artery</p><p>&#8226; diastolic flow in LPA&#8201;&gt;&#8201;0.2&#160;cm/sec</p><p>and&#8201;&#8805;&#8201;1 of the following clinical characteristics:</p><p>&#8226; oxygen-dependency at 72&#160;h of life</p><p>&#8226; increase in systemic differential pressure concomitant with decrease in systemic pressure</p></td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">LPA</italic>&#160;left pulmonary artery</p></table-wrap-foot></table-wrap></p><p id="Par14">The El-Khuffash&#8217;s PDA severity score was calculated immediately after echocardiographies using the formula: (gestation in weeks&#8201;&#215;&#8201;&#8201;&#8722;&#8201;1.304)&#8201;+&#8201;(PDA diameter in mm&#8201;&#215;&#8201;0.781)&#8201;+&#8201;(Left ventricular output in ml/kg/min&#8201;&#215;&#8201;0.008)&#8201;+&#8201;(maximum PDA velocity in m/s x&#8201;&#8722;&#8201;1.065)&#8201;+&#8201;(Left ventricular a&#8242; wave in cm/s x&#8201;&#8722;&#8201;0.470)&#8201;+&#8201;41 [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>].</p><p id="Par15">Echocardiographies were repeated at least at the end of each pharmacological course. All ultrasound studies were performed by pediatric cardiologists or by neonatologists trained for neonatal echocardiography (4 in Florence and 13 in Paris).</p><p id="Par16">Infants who developed hsPDA were treated as per local protocol. Intravenous ibuprofen was given at the standard dose of 10&#160;mg/kg followed, after 24 and 48&#160;h, by 5&#160;mg/kg. Intravenous paracetamol was given at a dose of 15&#160;mg/kg/6&#160;h for three days. Paracetamol was given as a first choice when patients had contraindications to ibuprofen (serum creatinine concentration&#8201;&gt;&#8201;1.5&#160;mg/dL, urine output&#8201;&lt;&#8201;1&#160;mL/kg/h or&#8201;&lt;&#8201;0.5&#160;mL/kg/h during the first 24&#160;h of life; platelet count&#8201;&lt;&#8201;50,000/mm<sup>3</sup>, IVH&#8201;&#8805;&#8201;grade 3). High-dose ibuprofen, paracetamol, or the combination of ibuprofen plus paracetamol could be given when the first course of ibuprofen failed. The treatment was decided by the neonatologist on duty.</p></sec><sec id="Sec6"><title>Recording of clinical data</title><p id="Par17">Clinical and demographic data were prospectively collected and reported in Table <xref rid="Tab2" ref-type="table">2</xref>.&#160;BPD was defined as oxygen requirement at 36&#160;weeks PMA [<xref ref-type="bibr" rid="CR18">18</xref>]. NEC was defined as Bell&#8217;s stage 2 or higher [<xref ref-type="bibr" rid="CR19">19</xref>]. IVH was diagnosed and staged according to the classification of Papile et al. [<xref ref-type="bibr" rid="CR20">20</xref>]. ROP was diagnosed according to International Classification of ROP [<xref ref-type="bibr" rid="CR21">21</xref>].
<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Baseline clinical characteristics of the infants and their mothers whose PDA was evaluated for hemodynamic significance. Mean&#8201;&#177;&#8201;(SD), or rate and (%), or median and (IQR)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Characteristics</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic>&#8201;=&#8201;41</th></tr></thead><tbody><tr><td align="left" colspan="2" rowspan="1">Infants</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Gestational age (wks)</td><td align="left" colspan="1" rowspan="1">28.0&#8201;&#177;&#8201;1.9</td></tr><tr><td align="left" colspan="1" rowspan="1"><p>Birth weight (g)</p><p>&#8201;&lt;&#8201;10th percentile</p><p>&#8201;&lt;&#8201;26&#160;weeks of gestational age</p></td><td align="left" colspan="1" rowspan="1"><p>986&#8201;&#177;&#8201;270</p><p>8 (20)</p><p>6 (15)</p></td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Female</td><td align="left" colspan="1" rowspan="1">20 (49)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Apgar score 5&#176;min</td><td align="left" colspan="1" rowspan="1">8 (6&#8211;9)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Noninvasive ventilation</td><td align="left" colspan="1" rowspan="1">41 (100)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Mechanical ventilation</td><td align="left" colspan="1" rowspan="1">9 (22)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Surfactant</td><td align="left" colspan="1" rowspan="1">23 (56)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Pulmonary hemorrhage</td><td align="left" colspan="1" rowspan="1">6 (15)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Necrotizing enterocolitis</td><td align="left" colspan="1" rowspan="1">2 (5)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Bronchopulmonary dysplasia</td><td align="left" colspan="1" rowspan="1">15 (37)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Intraventricular hemorrhage</td><td align="left" colspan="1" rowspan="1">6 (15)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Death</td><td align="left" colspan="1" rowspan="1">5 (12)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Duration of hospital stay (d)</td><td align="left" colspan="1" rowspan="1">47&#8201;&#177;&#8201;22</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Characteristics</td><td align="left" colspan="1" rowspan="1"><bold><italic toggle="yes">N</italic></bold>&#8201;=&#8201;41</td></tr><tr><td align="left" colspan="2" rowspan="1">Mothers</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Antenatal steroids</td><td align="left" colspan="1" rowspan="1">35 (85)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Cesarean section</td><td align="left" colspan="1" rowspan="1">29 (71)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Gestational diabetes</td><td align="left" colspan="1" rowspan="1">4 (10)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Hypertensive disorders of pregnancy</td><td align="left" colspan="1" rowspan="1">10 (24)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Chorioamnionitis</td><td align="left" colspan="1" rowspan="1">4 (10)</td></tr></tbody></table></table-wrap></p><p id="Par18">For each infant studied, we reported in Table <xref rid="Tab3" ref-type="table">3</xref> the diagnosis of hsPDA, measured echocardiographic parameters, treatment with ibuprofen and/or paracetamol, number of pharmacological courses, therapeutic success or failure, and need for surgical closure.
<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>Clinical characteristics, echocardiography parameters at the first and second echocardiography, and treatment of hsPDA in studied infants. Mean&#8201;&#177;&#8201;(SD), or rate and (%)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Characteristics</th><th align="left" colspan="1" rowspan="1">First echocardiography (<italic toggle="yes">n</italic>&#8201;=&#8201;41)</th><th align="left" colspan="1" rowspan="1">Second echocardiography (<italic toggle="yes">n</italic>&#8201;=&#8201;24)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic></th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Gestational age (wks)</td><td align="left" colspan="1" rowspan="1">28.1&#8201;&#177;&#8201;1.9</td><td align="left" colspan="1" rowspan="1">28.4&#8201;&#177;&#8201;1.9</td><td align="left" colspan="1" rowspan="1">0.541</td></tr><tr><td align="left" colspan="1" rowspan="1">Weight (g)</td><td align="left" colspan="1" rowspan="1">957&#8201;&#177;&#8201;255</td><td align="left" colspan="1" rowspan="1">896&#8201;&#177;&#8201;220</td><td align="left" colspan="1" rowspan="1">0.332</td></tr><tr><td align="left" colspan="1" rowspan="1">Noninvasive ventilation</td><td align="left" colspan="1" rowspan="1">33 (80)</td><td align="left" colspan="1" rowspan="1">12 (50)</td><td align="left" colspan="1" rowspan="1">0.022</td></tr><tr><td align="left" colspan="1" rowspan="1">Mechanical ventilation</td><td align="left" colspan="1" rowspan="1">9 (22)</td><td align="left" colspan="1" rowspan="1">12 (50)</td><td align="left" colspan="1" rowspan="1">0.040</td></tr><tr><td align="left" colspan="1" rowspan="1">Mean airway pressure (cm H<sub>2</sub>O)</td><td align="left" colspan="1" rowspan="1">8.0&#8201;&#177;&#8201;2.4</td><td align="left" colspan="1" rowspan="1">8.5&#8201;&#177;&#8201;3.3</td><td align="left" colspan="1" rowspan="1">0.484</td></tr><tr><td align="left" colspan="1" rowspan="1">SpO<sub>2</sub>/FiO<sub>2</sub></td><td align="left" colspan="1" rowspan="1">435&#8201;&#177;&#8201;51</td><td align="left" colspan="1" rowspan="1">423&#8201;&#177;&#8201;62</td><td align="left" colspan="1" rowspan="1">0.401</td></tr><tr><td align="left" colspan="1" rowspan="1"><p>Systemic systolic pressure (mmHg)</p><p>Systemic diastolic pressure</p><p>Mean systemic pressure</p></td><td align="left" colspan="1" rowspan="1"><p>58&#8201;&#177;&#8201;9</p><p>37&#8201;&#177;&#8201;9</p><p>44&#8201;&#177;&#8201;8</p></td><td align="left" colspan="1" rowspan="1"><p>58&#8201;&#177;&#8201;10</p><p>35&#8201;&#177;&#8201;10</p><p>41&#8201;&#177;&#8201;13</p></td><td align="left" colspan="1" rowspan="1"><p>1.000</p><p>0.410</p><p>0.253</p></td></tr><tr><td align="left" colspan="1" rowspan="1"><p>La/Ao ratio</p><p>PDA diameter (mm)</p><p>PDA diameter (mm/kg)</p></td><td align="left" colspan="1" rowspan="1"><p>1.3&#8201;&#177;&#8201;0.2</p><p>1.4&#8201;&#177;&#8201;0.5</p><p>1.4&#8201;&#177;&#8201;0.7</p></td><td align="left" colspan="1" rowspan="1"><p>1.5&#8201;&#177;&#8201;0.2</p><p>1.6&#8201;&#177;&#8201;0.4</p><p>1.7&#8201;&#177;&#8201;0.7</p></td><td align="left" colspan="1" rowspan="1"><p>&#8201;&lt;&#8201;0.001</p><p>0.010</p><p>0.100</p></td></tr><tr><td align="left" colspan="1" rowspan="1">Peak velocity of PDA (cm/sec)</td><td align="left" colspan="1" rowspan="1">1.9&#8201;&#177;&#8201;0.5</td><td align="left" colspan="1" rowspan="1">1.8&#8201;&#177;&#8201;0.8</td><td align="left" colspan="1" rowspan="1">0.537</td></tr><tr><td align="left" colspan="1" rowspan="1">Pulsatile flow pattern</td><td align="left" colspan="1" rowspan="1">13 (32)</td><td align="left" colspan="1" rowspan="1">12 (50)</td><td align="left" colspan="1" rowspan="1">0.231</td></tr><tr><td align="left" colspan="1" rowspan="1">Left ventricular output (ml/kg/min)</td><td align="left" colspan="1" rowspan="1">206&#8201;&#177;&#8201;67</td><td align="left" colspan="1" rowspan="1">278&#8201;&#177;&#8201;81</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Left ventricular a&#8242; wave (cm/sec)</td><td align="left" colspan="1" rowspan="1">5.5&#8201;&#177;&#8201;1.8</td><td align="left" colspan="1" rowspan="1">4.5&#8201;&#177;&#8201;0.9</td><td align="left" colspan="1" rowspan="1">0.014</td></tr><tr><td align="left" colspan="1" rowspan="1">Diastolic flow in LPA (cm/sec)</td><td align="left" colspan="1" rowspan="1">0.15&#8201;&#177;&#8201;0.10</td><td align="left" colspan="1" rowspan="1">0.29&#8201;&#177;&#8201;0.28</td><td align="left" colspan="1" rowspan="1">0.005</td></tr><tr><td align="left" colspan="1" rowspan="1">Absence of arterial mesenteric diastolic flow</td><td align="left" colspan="1" rowspan="1">5 (12)</td><td align="left" colspan="1" rowspan="1">11 (46)</td><td align="left" colspan="1" rowspan="1">0.006</td></tr><tr><td align="left" colspan="1" rowspan="1">Cerebral resistant index</td><td align="left" colspan="1" rowspan="1">0.73&#8201;&#177;&#8201;0.06</td><td align="left" colspan="1" rowspan="1">0.79&#8201;&#177;&#8201;0.09</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">PDA severity score</td><td align="left" colspan="1" rowspan="1">2.9&#8201;&#177;&#8201;2.7</td><td align="left" colspan="1" rowspan="1">4.8&#8201;&#177;&#8201;2.6</td><td align="left" colspan="1" rowspan="1">0.007</td></tr><tr><td align="left" colspan="1" rowspan="1">Pharmacological treatment of PDA</td><td align="left" colspan="3" rowspan="1">19 (46)</td></tr><tr><td align="left" colspan="1" rowspan="1"><p>One course of ibuprofen</p><p>Two courses of ibuprofen</p></td><td align="left" colspan="3" rowspan="1"><p>15 (37)</p><p>5 (12)</p></td></tr><tr><td align="left" colspan="1" rowspan="1"><p>One course of paracetamol</p><p>Two courses of paracetamol</p></td><td align="left" colspan="3" rowspan="1"><p>8 (20)</p><p>5 (12)</p></td></tr><tr><td align="left" colspan="1" rowspan="1">Ibuprofen plus paracetamol</td><td align="left" colspan="3" rowspan="1">4 (10)</td></tr><tr><td align="left" colspan="1" rowspan="1">Surgical closure</td><td align="left" colspan="3" rowspan="1">1 (2)</td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">LPA</italic>&#160;left pulmonary artery</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec7"><title>Statistical analysis</title><p id="Par19">The quantitative clinical characteristics of infants were described as mean and SD for normally distributed values or as median and IQR for nonnormally distributed variables. Categorical variables were reported with frequencies and percentage. Continuous and categorical variables were compared using the Student <italic toggle="yes">t</italic> test or the Wilcoxon rank sum test for non-parametric continuous variables and &#935;<sup>2</sup>&#160;test for categorical variables, respectively. A P value&#8201;&lt;&#8201;0.05 was considered statistically significant.</p><p id="Par20">Concordance between Florence criteria, Paris criteria, and PDA severity score for the diagnosis of hsPDA was evaluated with the Cohen unweighted &#954; statistic. Kappa statistics was interpreted as following: less than 0.2 represents poor agreement; 0.2&#8211;0.4 represents fair agreement; 0.41&#8211;0.6 represents moderate agreement; 0.61&#8211;0.8 represents substantial agreement; greater than 0.8 represents great agreement [<xref ref-type="bibr" rid="CR22">22</xref>].</p><p id="Par21">Assuming a <italic toggle="yes">&#954;</italic> coefficient of correlation of 0.85 between Florence and Paris echocardiographic criteria, a sample size of 65 echocardiographies was calculated to obtain a statistical power of 90% with <italic toggle="yes">&#945;</italic>&#8201;=&#8201;0.05.</p></sec></sec><sec id="Sec8"><title>Results</title><p id="Par22">We studied 41 infants (8 in Florence and 33 in Paris) with a gestational age of 28.0&#8201;&#177;&#8201;1.9&#160;weeks and a birth weight of 986&#8201;&#177;&#8201;270&#160;g whose clinical characteristics are detailed in Table&#160;<xref rid="Tab2" ref-type="table">2</xref>. Patients underwent the first (<italic toggle="yes">n</italic>&#8201;=&#8201;41) and second (<italic toggle="yes">n</italic>&#8201;=&#8201;24) echocardiography at 28.1&#8201;&#177;&#8201;1.9 and 28.4&#8201;&#177;&#8201;1.9&#160;weeks of gestational age, respectively.</p><p id="Par23">We observed that La/Ao ratio, left ventricular cardiac output, diastolic flow in LPA, absence of arterial mesenteric diastolic flow, cerebral resistant index, and PDA score increased from the first to the second echocardiography, while left ventricular a&#8242; wave decreased (Table&#160;<xref rid="Tab3" ref-type="table">3</xref>).
</p><p id="Par24">The overall incidence of hsPDA diagnosed by the Florence (35%) or Paris (34%) criteria or by PDA severity score (35%) was similar. The frequency of hsPDA increased from the first to the second echocardiography, but the difference was statistically significant only for the Florence and Paris criteria (Table&#160;<xref rid="Tab4" ref-type="table">4</xref>).
<table-wrap id="Tab4" position="float" orientation="portrait"><label>Table 4</label><caption><p>Frequency of hsPDA using Florence criteria, Paris criteria, or PDA score. Rate and (%)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">All echocardiographies (<italic toggle="yes">n</italic>&#8201;=&#8201;65)</th><th align="left" colspan="1" rowspan="1">First echocardiography (<italic toggle="yes">n</italic>&#8201;=&#8201;41)</th><th align="left" colspan="1" rowspan="1">Second echocardiography (<italic toggle="yes">n</italic>&#8201;=&#8201;24)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic><break/>1&#8201;st vs 2nd<break/>echocardiography</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Florence criteria</td><td align="left" colspan="1" rowspan="1">23 (35)</td><td align="left" colspan="1" rowspan="1">8 (20)</td><td align="left" colspan="1" rowspan="1">15 (63)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Paris criteria</td><td align="left" colspan="1" rowspan="1">22 (34)</td><td align="left" colspan="1" rowspan="1">5 (12)</td><td align="left" colspan="1" rowspan="1">17 (71)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">PDA score</td><td align="left" colspan="1" rowspan="1">23 (35)</td><td align="left" colspan="1" rowspan="1">11 (27)</td><td align="left" colspan="1" rowspan="1">12 (50)</td><td char="." align="char" colspan="1" rowspan="1">0.06</td></tr></tbody></table></table-wrap></p><p id="Par25">Nineteen (46%) infants had pharmacological treatment for hsPDA, 12 (29%) in Paris and 7 (17%) in Florence. Among them, 15 (37%) were treated with ibuprofen and 8 (20%) with paracetamol. Four (10%) patients were given both ibuprofen and paracetamol (Table&#160;<xref rid="Tab3" ref-type="table">3</xref>). Among untreated infants, only one patient had a diagnosis of hsPDA (with PDA severity score). Surgical closure of the PDA was necessary in only one patient.</p><p id="Par26">The Florence and Paris criteria had an overall concordance of 83% (54/65 diagnoses), with a &#954; statistic of 0.626 (95% C.l. 0.427&#8211;0.826). The Florence criteria compared with the PDA severity score had an overall concordance of 85% (55/65 diagnoses), with a &#954; statistic of 0.664 (95% C.l. 0.473&#8211;0.854). The Paris criteria compared with the PDA severity score had an overall concordance of 64% (42/65 diagnoses), with a &#954; statistic of 0.219 (95% C.l. &#8722;0.026&#8211;0.463). At the first echocardiography, Florence criteria had a moderate agreement with Paris criteria and PDA severity score, while Paris criteria had a fair agreement with the PDA severity score. At the second echocardiography, Florence criteria had a fair agreement with Paris criteria and moderate agreement with the PDA severity score, while Paris criteria had a poor agreement with PDA severity score (Table&#160;<xref rid="Tab5" ref-type="table">5</xref>, Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>).</p><p id="Par27">
<table-wrap id="Tab5" position="float" orientation="portrait"><label>Table 5</label><caption><p>Concordance and <italic toggle="yes">k</italic> statistic between Florence criteria, Paris criteria, and PDA score for the diagnosis of hsPDA. Rate and (%) or <italic toggle="yes">k</italic> statistic and (95% CI)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">All echocardiographies (<italic toggle="yes">n</italic>&#8201;=&#8201;65)</th><th align="left" colspan="1" rowspan="1">First echocardiography (<italic toggle="yes">n</italic>&#8201;=&#8201;41)</th><th align="left" colspan="1" rowspan="1">Second echocardiography (<italic toggle="yes">n</italic>&#8201;=&#8201;24)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1"><p>Florence vs Paris criteria</p><p>Concordance</p><p><italic toggle="yes">k</italic> statistic</p></td><td char="&#x2013;" align="char" colspan="1" rowspan="1"><p>54 (83)</p><p>0.626 (0.427&#8211;0.826)</p></td><td char="&#x2013;" align="char" colspan="1" rowspan="1"><p>38 (93)</p><p>0.728 (0.444&#8211;1.000)</p></td><td char="&#x2013;" align="char" colspan="1" rowspan="1"><p>16 (67)</p><p>0.256 (&#8722;&#8201;0.140&#8211;0.652)</p></td></tr><tr><td align="left" colspan="1" rowspan="1"><p>Florence criteria vs PDA score</p><p>Concordance</p><p><italic toggle="yes">k</italic> statistic</p></td><td char="&#x2013;" align="char" colspan="1" rowspan="1"><p>55 (85)</p><p>0.664 (0.473&#8211;0.854)</p></td><td char="&#x2013;" align="char" colspan="1" rowspan="1"><p>34 (83)</p><p>0.524 (0.220&#8211;0.828)</p></td><td char="&#x2013;" align="char" colspan="1" rowspan="1"><p>21 (88)</p><p>0.750 (0.494&#8211;1.000)</p></td></tr><tr><td align="left" colspan="1" rowspan="1"><p>Paris criteria vs PDA score</p><p>Concordance</p><p><italic toggle="yes">k</italic> statistic</p></td><td char="&#x2013;" align="char" colspan="1" rowspan="1"><p>42 (64)</p><p>0.219 (&#8722;&#8201;0.026&#8211;0.463)</p></td><td char="&#x2013;" align="char" colspan="1" rowspan="1"><p>29 (80)</p><p>0.399 (0.081&#8211;0.718)</p></td><td char="&#x2013;" align="char" colspan="1" rowspan="1"><p>13 (54)</p><p>0.083 (&#8722;&#8201;0.279&#8211;0.446)</p></td></tr></tbody></table></table-wrap><fig id="Fig1" position="float" orientation="portrait"><label>Fig.&#160;1</label><caption><p>Diagnostic results of Florence criteria, Paris criteria, and PDA severity score at <bold>a</bold> the first and <bold>b</bold> the second echocardiography. Each white block represents a diagnosis of no hsPDA, while each black block represents a hsPDA diagnosis</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="431_2025_6485_Fig1_HTML.jpg"/></fig></p></sec><sec id="Sec9"><title>Discussion</title><p id="Par28">In this study, we evaluated for the first time how different diagnostic criteria used at different postnatal times may influence the diagnosis of hsPDA in very preterm infants. We found that the Florence and Paris criteria and the PDA severity score detected a similar rate of hsPDA diagnosis. Furthermore, subanalysis of the results showed that the first echocardiography detected a lower frequency of hsPDA than the second, with no differences among the three diagnostic criteria. This finding can be explained by the increase of values of most echocardiographic parameters included in the Florence and Paris criteria and in the PDA severity score. In fact, PDA diameter, left atrium to aortic root ratio (LA/Ao), left ventricular output, diastolic flow in left pulmonary artery (LPA), cerebral resistance index, and the absence of arterial mesenteric diastolic flow were increased in the second echocardiography.</p><p id="Par29">However, when we calculated the concordance between the three criteria, we found significant diagnostic differences. This suggests that choosing one criterion rather than another could lead to treating different patients at different times while leaving their overall percentages unchanged. Overall, the Florence and Paris criteria showed a substantial agreement, but this was due to the results of the first echocardiography and not of the second, since their concordance were 93 and 67%, respectively. The Florence and PDA severity score criteria showed a substantial agreement, but the agreement was moderate (83%) at the first echocardiography and substantial (88%) at the second. Finally, the Paris and PDA severity score criteria had a fair agreement since the concordance was fair (80%) at the first echocardiography and became poor (54%) at the second.</p><p id="Par30">These differences were likely due to the difference between the criteria studied, pathophysiological changes over time in the measured ultrasound parameters and, probably to a lesser extent, to the clinical parameters included in the Paris criteria and the PDA severity score [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. In particular, the criteria for diagnosing hsPDA are likely to be influenced by the decrease in pulmonary vascular resistance and the increase in right and left ventricular output that are expected to occur during the transition phase [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. In any case, these results clearly demonstrated that the choice of the diagnostic criteria and the timing of their application can influence hsPDA diagnosis and treatment.</p><p id="Par31">Considering these findings, it is reasonable to ask whether there are better parameters or scores than those we studied for diagnosing hsPDA, such as the IOWA PDA score [<xref ref-type="bibr" rid="CR25">25</xref>]. However, it is not possible to provide an answer at this time, given the complexity of the condition, the large number of parameters measurable at different postnatal ages, and the subjectivity of the measurements.</p><p id="Par32">It can be observed that the frequency of hsPDA in our population was quite high. We believe this is due to the short duration of enrollment, which caused a selection bias, and that the high frequency of hsPDA was due to chance.</p><p id="Par33">Our study has some limitations. The two participating centers used local criteria for the diagnosis of hsPDA and to decide its management, and neither of them used the PDA severity score. Therefore, we could not effectively evaluate the effects of applying these diagnostic methods on the management of PDA in clinical practice, as a randomized controlled trial could do. In addition, we achieved the planned sample size of 65 total echocardiographies, but the number of the first and second echocardiographies was lower, and the corresponding subanalyses may not have optimal statistical power. The study population was&#8201;&lt;&#8201;32&#160;weeks of gestation and, therefore, our results may not reflect the conditions of more immature infants, which limits the generalizability of the findings.</p><p id="Par34">In conclusion, the studied diagnostic criteria showed important variations of concordance when applied at different times. This led to diagnose hsPDA in different patients at different times while leaving the overall percentage of hsPDA unchanged. Our results suggest that more attention should be paid to the choice of diagnostic criteria for individuating hsPDA in very preterm infants.</p></sec></body><back><glossary id="AGS1"><title>Abbreviations</title><def-list><def-item><term>BPD</term><def><p id="Par3">Bronchopulmonary dysplasia</p></def></def-item><def-item><term>hsPDA</term><def><p id="Par4">Hemodynamically significant patent ductus arteriosus</p></def></def-item><def-item><term>NICU</term><def><p id="Par5">Neonatal intensive care units</p></def></def-item><def-item><term>PDA</term><def><p id="Par6">Patent ductus arteriosus</p></def></def-item><def-item><term>RDS</term><def><p id="Par7">Respiratory distress syndrome</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes notes-type="author-contribution"><title>Authors&#8217; Contributions</title><p>CD, DDL: Conceptualization, methodology, formal analysis, validation, writing original draft. DS, IC, SP, CP, SM, BL, GC GR:&#160; Investigation, methodology, validation,writing (review and editing).</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Open access funding provided by Universit&#224; degli Studi di Firenze within the CRUI-CARE Agreement.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>Data are available on reasoned request.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval</title><p id="Par35">This study was conducted according to the guidelines of the Declaration of Helsinki. The study involves human participants and was approved by the Tuscany pediatric ethics committee and CER of Paris Saclay.</p></notes><notes id="FPar2" notes-type="COI-statement"><title>Competing interests</title><p id="Par36">CD received honoraria from Chiesi Farmaceutici Spa, Vyaire Medical Inc., Sanofi Italia, and GEPA Srl for scientific consultancies. Remaining authors declare that they have no competing interests.&#160;DDL is an Editor of the European Journal of Pediatrics.</p></notes></notes><ref-list id="Bib1"><title>References
</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ambalavanan</surname><given-names>N</given-names></name><name name-style="western"><surname>Aucott</surname><given-names>SW</given-names></name><name name-style="western"><surname>Salavitabar</surname><given-names>A</given-names></name><name name-style="western"><surname>Levy</surname><given-names>VY</given-names></name><collab>Committee on fetus and newborn; section on cardiology and cardiac surgery</collab></person-group><article-title>Patent ductus arteriosus in preterm infants</article-title><source>Pediatrics</source><year>2025</year><volume>155</volume><fpage>e2025071425</fpage><pub-id pub-id-type="doi">10.1542/peds.2025-071425</pub-id><pub-id pub-id-type="pmid">40288780</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Ambalavanan N, Aucott SW, Salavitabar A, Levy VY, Committee on fetus and newborn; section on cardiology and cardiac surgery (2025) Patent ductus arteriosus in preterm infants. Pediatrics 155:e2025071425<pub-id pub-id-type="pmid">40288780</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1542/peds.2025-071425</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="other"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://nightingale.vtoxford.org/charts/home">https://nightingale.vtoxford.org/charts/home</ext-link>. Accessed&#160; 4&#160;Aug&#160; 2025</mixed-citation></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>A</given-names></name><name name-style="western"><surname>El-Khuffash</surname><given-names>A</given-names></name></person-group><article-title>Patent ductus arteriosus clinical trials: lessons learned and future directions</article-title><source>Children (Basel)</source><year>2021</year><volume>8</volume><fpage>47</fpage><pub-id pub-id-type="pmid">33467401</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/children8010047</pub-id><pub-id pub-id-type="pmcid">PMC7830584</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Smith A, El-Khuffash A (2021) Patent ductus arteriosus clinical trials: lessons learned and future directions. Children (Basel) 8:47<pub-id pub-id-type="pmid">33467401</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/children8010047</pub-id><pub-id pub-id-type="pmcid">PMC7830584</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hundscheid</surname><given-names>T</given-names></name><name name-style="western"><surname>Onland</surname><given-names>W</given-names></name><name name-style="western"><surname>Kooi</surname><given-names>EMW</given-names></name><etal/></person-group><article-title>Expectant management or early ibuprofen for patent ductus arteriosus</article-title><source>N Engl J Med</source><year>2023</year><volume>388</volume><fpage>980</fpage><lpage>990</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2207418</pub-id><pub-id pub-id-type="pmid">36477458</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Hundscheid T, Onland W, Kooi EMW et al (2023) Expectant management or early ibuprofen for patent ductus arteriosus. N Engl J Med 388:980&#8211;990<pub-id pub-id-type="pmid">36477458</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa2207418</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gupta</surname><given-names>S</given-names></name><name name-style="western"><surname>Subhedar</surname><given-names>NV</given-names></name><name name-style="western"><surname>Bell</surname><given-names>JL</given-names></name></person-group><article-title>Trial of selective early treatment of patent ductus arteriosus with ibuprofen</article-title><source>N Engl J Med</source><year>2024</year><volume>390</volume><fpage>314</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2305582</pub-id><pub-id pub-id-type="pmid">38265644</pub-id><pub-id pub-id-type="pmcid">PMC7615774</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Gupta S, Subhedar NV, Bell JL (2024) Trial of selective early treatment of patent ductus arteriosus with ibuprofen. N Engl J Med 390:314&#8211;325<pub-id pub-id-type="pmid">38265644</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa2305582</pub-id><pub-id pub-id-type="pmcid">PMC7615774</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Altit</surname><given-names>G</given-names></name><name name-style="western"><surname>Saeed</surname><given-names>S</given-names></name><name name-style="western"><surname>Beltempo</surname><given-names>M</given-names></name><etal/></person-group><article-title>Outcomes of extremely premature infants comparing patent ductus arteriosus management approaches</article-title><source>J Pediatr</source><year>2021</year><volume>235</volume><fpage>49</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.jpeds.2021.04.014</pub-id><pub-id pub-id-type="pmid">33864797</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Altit G, Saeed S, Beltempo M et al (2021) Outcomes of extremely premature infants comparing patent ductus arteriosus management approaches. J Pediatr 235:49&#8211;57<pub-id pub-id-type="pmid">33864797</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpeds.2021.04.014</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Relangi</surname><given-names>D</given-names></name><name name-style="western"><surname>Somashekar</surname><given-names>S</given-names></name><name name-style="western"><surname>Jain</surname><given-names>D</given-names></name></person-group><article-title>Changes in patent ductus arteriosus treatment strategy and respiratory outcomes in premature infants</article-title><source>J Pediatr</source><year>2021</year><volume>235</volume><fpage>58</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.jpeds.2021.04.030</pub-id><pub-id pub-id-type="pmid">33894266</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Relangi D, Somashekar S, Jain D (2021) Changes in patent ductus arteriosus treatment strategy and respiratory outcomes in premature infants. J Pediatr 235:58&#8211;62<pub-id pub-id-type="pmid">33894266</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpeds.2021.04.030</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Villamor</surname><given-names>E</given-names></name><name name-style="western"><surname>van Westering-Kroon</surname><given-names>E</given-names></name><name name-style="western"><surname>Gonzalez-Luis</surname><given-names>GE</given-names></name><etal/></person-group><article-title>Patent ductus arteriosus and bronchopulmonary dysplasia-associated pulmonary hypertension: a bayesian meta-analysis</article-title><source>JAMA Netw Open</source><year>2023</year><volume>6</volume><fpage>e2345299</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2023.45299</pub-id><pub-id pub-id-type="pmid">38015504</pub-id><pub-id pub-id-type="pmcid">PMC10685885</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Villamor E, van Westering-Kroon E, Gonzalez-Luis GE et al (2023) Patent ductus arteriosus and bronchopulmonary dysplasia-associated pulmonary hypertension: a bayesian meta-analysis. JAMA Netw Open 6:e2345299<pub-id pub-id-type="pmid">38015504</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamanetworkopen.2023.45299</pub-id><pub-id pub-id-type="pmcid">PMC10685885</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kikuchi</surname><given-names>N</given-names></name><name name-style="western"><surname>Goto</surname><given-names>T</given-names></name><name name-style="western"><surname>Katsumata</surname><given-names>N</given-names></name><name name-style="western"><surname>Murakami</surname><given-names>Y</given-names></name></person-group><article-title>Correlation between the closure time of patent ductus arteriosus in preterm infants and long-term neurodevelopmental outcome</article-title><source>J Cardiovasc Dev Dis</source><year>2024</year><volume>11</volume><fpage>26</fpage><pub-id pub-id-type="pmid">38248896</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/jcdd11010026</pub-id><pub-id pub-id-type="pmcid">PMC10816731</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Kikuchi N, Goto T, Katsumata N, Murakami Y (2024) Correlation between the closure time of patent ductus arteriosus in preterm infants and long-term neurodevelopmental outcome. J Cardiovasc Dev Dis 11:26<pub-id pub-id-type="pmid">38248896</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/jcdd11010026</pub-id><pub-id pub-id-type="pmcid">PMC10816731</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mitra</surname><given-names>S</given-names></name><name name-style="western"><surname>Bischoff</surname><given-names>AR</given-names></name><name name-style="western"><surname>Sathanandam</surname><given-names>S</given-names></name><etal/></person-group><article-title>Procedural closure of patent ductus arteriosus: a clinical practice guideline</article-title><source>J Perinatol</source><year>2024</year><volume>44</volume><fpage>1402</fpage><lpage>1408</lpage><pub-id pub-id-type="doi">10.1038/s41372-024-02052-9</pub-id><pub-id pub-id-type="pmid">38997403</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Mitra S, Bischoff AR, Sathanandam S et al (2024) Procedural closure of patent ductus arteriosus: a clinical practice guideline. J Perinatol 44:1402&#8211;1408<pub-id pub-id-type="pmid">38997403</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41372-024-02052-9</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>El-Khuffash</surname><given-names>A</given-names></name><name name-style="western"><surname>James</surname><given-names>AT</given-names></name><name name-style="western"><surname>Corcoran</surname><given-names>JD</given-names></name><name name-style="western"><surname>Dicker</surname><given-names>P</given-names></name><name name-style="western"><surname>Franklin</surname><given-names>O</given-names></name><name name-style="western"><surname>Elsayed</surname><given-names>YN</given-names></name><etal/></person-group><article-title>A patent ductus arteriosus severity score predicts chronic lung disease or death before discharge</article-title><source>J Pediatr</source><year>2015</year><volume>167</volume><fpage>1354</fpage><lpage>1361.e2</lpage><pub-id pub-id-type="doi">10.1016/j.jpeds.2015.09.028</pub-id><pub-id pub-id-type="pmid">26474706</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">El-Khuffash A, James AT, Corcoran JD, Dicker P, Franklin O, Elsayed YN et al (2015) A patent ductus arteriosus severity score predicts chronic lung disease or death before discharge. J Pediatr 167:1354-1361.e2<pub-id pub-id-type="pmid">26474706</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpeds.2015.09.028</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brissaud</surname><given-names>O</given-names></name><name name-style="western"><surname>Guichoux</surname><given-names>J</given-names></name></person-group><article-title>Patent ductus arteriosus in the preterm infant: a survey of clinical practices in French neonatal intensive care units</article-title><source>Pediatr Cardiol</source><year>2011</year><volume>32</volume><fpage>607</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.1007/s00246-011-9925-8</pub-id><pub-id pub-id-type="pmid">21360267</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Brissaud O, Guichoux J (2011) Patent ductus arteriosus in the preterm infant: a survey of clinical practices in French neonatal intensive care units. Pediatr Cardiol 32:607&#8211;614<pub-id pub-id-type="pmid">21360267</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00246-011-9925-8</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Su</surname><given-names>BH</given-names></name><name name-style="western"><surname>Peng</surname><given-names>CT</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>CH</given-names></name></person-group><article-title>Echocardiographic flow pattern of patent ductus arteriosus: a guide to indomethacin treatment in premature infants</article-title><source>Arch Dis Child Fetal Neonatal Ed</source><year>1999</year><volume>81</volume><fpage>F197</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1136/fn.81.3.F197</pub-id><pub-id pub-id-type="pmid">10525023</pub-id><pub-id pub-id-type="pmcid">PMC1721002</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Su BH, Peng CT, Tsai CH (1999) Echocardiographic flow pattern of patent ductus arteriosus: a guide to indomethacin treatment in premature infants. Arch Dis Child Fetal Neonatal Ed 81:F197-200<pub-id pub-id-type="pmid">10525023</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/fn.81.3.f197</pub-id><pub-id pub-id-type="pmcid">PMC1721002</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sathanandam</surname><given-names>S</given-names></name><name name-style="western"><surname>Whiting</surname><given-names>S</given-names></name><name name-style="western"><surname>Cunningham</surname><given-names>J</given-names></name><etal/></person-group><article-title>Practice variation in the management of patent ductus arteriosus in extremely low birth weight infants in the United States: survey results among cardiologists and neonatologists</article-title><source>Congenit Heart Dis</source><year>2019</year><volume>14</volume><fpage>6</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1111/chd.12729</pub-id><pub-id pub-id-type="pmid">30811803</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Sathanandam S, Whiting S, Cunningham J et al (2019) Practice variation in the management of patent ductus arteriosus in extremely low birth weight infants in the United States: survey results among cardiologists and neonatologists. Congenit Heart Dis 14:6&#8211;14<pub-id pub-id-type="pmid">30811803</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/chd.12729</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hajjar</surname><given-names>ME</given-names></name><name name-style="western"><surname>Vaksmann</surname><given-names>G</given-names></name><name name-style="western"><surname>Rakza</surname><given-names>T</given-names></name></person-group><article-title>Severity of the ductal shunt: a comparison of different markers</article-title><source>Arch Dis Child Fetal Neonatal Ed</source><year>2005</year><volume>90</volume><fpage>F419</fpage><lpage>F422</lpage><pub-id pub-id-type="doi">10.1136/adc.2003.027698</pub-id><pub-id pub-id-type="pmid">16113155</pub-id><pub-id pub-id-type="pmcid">PMC1721944</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Hajjar ME, Vaksmann G, Rakza T (2005) Severity of the ductal shunt: a comparison of different markers. Arch Dis Child Fetal Neonatal Ed 90:F419&#8211;F422<pub-id pub-id-type="pmid">16113155</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/adc.2003.027698</pub-id><pub-id pub-id-type="pmcid">PMC1721944</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>A</given-names></name><name name-style="western"><surname>Mullaly</surname><given-names>R</given-names></name><name name-style="western"><surname>Franklin</surname><given-names>O</given-names></name><name name-style="western"><surname>El-Khuffash</surname><given-names>A</given-names></name></person-group><article-title>Reproducibility of the EL-khuffash PDA severity score and PDA diameter measurements in extremely preterm infants</article-title><source>Early Hum Dev</source><year>2023</year><volume>184</volume><fpage>105832</fpage><pub-id pub-id-type="doi">10.1016/j.earlhumdev.2023.105832</pub-id><pub-id pub-id-type="pmid">37515829</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Smith A, Mullaly R, Franklin O, El-Khuffash A (2023) Reproducibility of the EL-khuffash PDA severity score and PDA diameter measurements in extremely preterm infants. Early Hum Dev 184:105832<pub-id pub-id-type="pmid">37515829</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.earlhumdev.2023.105832</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>El-Khuffash</surname><given-names>A</given-names></name><name name-style="western"><surname>Bussmann</surname><given-names>N</given-names></name><name name-style="western"><surname>Breatnach</surname><given-names>CR</given-names></name><name name-style="western"><surname>Smith</surname><given-names>A</given-names></name><name name-style="western"><surname>Tully</surname><given-names>E</given-names></name><name name-style="western"><surname>Griffin</surname><given-names>J</given-names></name><etal/></person-group><article-title>A pilot randomized controlled trial of early targeted patent ductus arteriosus treatment using a risk based severity score (the PDA RCT)</article-title><source>J Pediatr</source><year>2021</year><volume>229</volume><fpage>127</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1016/j.jpeds.2020.10.024</pub-id><pub-id pub-id-type="pmid">33069668</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">El-Khuffash A, Bussmann N, Breatnach CR, Smith A, Tully E, Griffin J et al (2021) A pilot randomized controlled trial of early targeted patent ductus arteriosus treatment using a risk based severity score (the PDA RCT). J Pediatr 229:127&#8211;133<pub-id pub-id-type="pmid">33069668</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpeds.2020.10.024</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ehrenkranz</surname><given-names>RA</given-names></name><name name-style="western"><surname>Walsh</surname><given-names>MC</given-names></name><name name-style="western"><surname>Vohr</surname><given-names>BR</given-names></name><name name-style="western"><surname>Jobe</surname><given-names>AH</given-names></name><name name-style="western"><surname>Wright</surname><given-names>LL</given-names></name><name name-style="western"><surname>Fanaroff</surname><given-names>AA</given-names></name><name name-style="western"><surname>Wrage</surname><given-names>LA</given-names></name><name name-style="western"><surname>Poole</surname><given-names>K</given-names></name><collab>National Institutes of Child Health and Human Development Neonatal Research Network</collab></person-group><article-title>Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia</article-title><source>Pediatrics</source><year>2005</year><volume>116</volume><fpage>1353</fpage><lpage>1360</lpage><pub-id pub-id-type="doi">10.1542/peds.2005-0249</pub-id><pub-id pub-id-type="pmid">16322158</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA, Wrage LA, Poole K, National Institutes of Child Health and Human Development Neonatal Research Network (2005) Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 116:1353&#8211;1360<pub-id pub-id-type="pmid">16322158</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1542/peds.2005-0249</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bell</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Ternberg</surname><given-names>JL</given-names></name><name name-style="western"><surname>Feigin</surname><given-names>RD</given-names></name><name name-style="western"><surname>Keating</surname><given-names>JP</given-names></name><name name-style="western"><surname>Marshall</surname><given-names>R</given-names></name><name name-style="western"><surname>Barton</surname><given-names>L</given-names></name><name name-style="western"><surname>Brotherton</surname><given-names>T</given-names></name></person-group><article-title>Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging</article-title><source>Ann Surg</source><year>1978</year><volume>187</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1097/00000658-197801000-00001</pub-id><pub-id pub-id-type="pmid">413500</pub-id><pub-id pub-id-type="pmcid">PMC1396409</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, Brotherton T (1978) Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging. Ann Surg 187:1&#8211;12<pub-id pub-id-type="pmid">413500</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00000658-197801000-00001</pub-id><pub-id pub-id-type="pmcid">PMC1396409</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Papile</surname><given-names>LA</given-names></name><name name-style="western"><surname>Burstein</surname><given-names>J</given-names></name><name name-style="western"><surname>Burstein</surname><given-names>RKH</given-names></name></person-group><article-title>Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1.500 gm</article-title><source>J Pediatr</source><year>1978</year><volume>92</volume><fpage>529</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1016/S0022-3476(78)80282-0</pub-id><pub-id pub-id-type="pmid">305471</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Papile LA, Burstein J, Burstein RKH (1978) Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1.500 gm. J Pediatr 92:529&#8211;534.<pub-id pub-id-type="pmid">305471</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0022-3476(78)80282-0</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><collab>International Committee for the Classification of the Retinopathy of Prematurity</collab></person-group><article-title>The international classification of retinopathy of prematurity revisited</article-title><source>Arch Ophthalmol</source><year>2005</year><volume>123</volume><fpage>991</fpage><lpage>999</lpage><pub-id pub-id-type="doi">10.1001/archopht.123.7.991</pub-id><pub-id pub-id-type="pmid">16009843</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">International Committee for the Classification of the Retinopathy of Prematurity (2005) The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 123:991&#8211;999<pub-id pub-id-type="pmid">16009843</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archopht.123.7.991</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Landis</surname><given-names>JR</given-names></name><name name-style="western"><surname>Koch</surname><given-names>GG</given-names></name></person-group><article-title>The measurement of observer agreement for categorical data</article-title><source>Biometrics</source><year>1977</year><volume>33</volume><fpage>159</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.2307/2529310</pub-id><pub-id pub-id-type="pmid">843571</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159&#8211;174<pub-id pub-id-type="pmid">843571</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>TW</given-names></name><name name-style="western"><surname>Azhibekov</surname><given-names>T</given-names></name><name name-style="western"><surname>Seri</surname><given-names>I</given-names></name></person-group><article-title>Transitional hemodynamics in preterm neonates: clinical relevance</article-title><source>Pediatr Neonatol</source><year>2016</year><volume>57</volume><fpage>7</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.pedneo.2015.07.002</pub-id><pub-id pub-id-type="pmid">26482579</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Wu TW, Azhibekov T, Seri I (2016) Transitional hemodynamics in preterm neonates: clinical relevance. Pediatr Neonatol 57:7&#8211;18<pub-id pub-id-type="pmid">26482579</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pedneo.2015.07.002</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hooper</surname><given-names>SB</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>C</given-names></name><name name-style="western"><surname>Dekker</surname><given-names>J</given-names></name><name name-style="western"><surname>Te Pas</surname><given-names>AB</given-names></name></person-group><article-title>Issues in cardiopulmonary transition at birth</article-title><source>Semin Fetal Neonatal Med</source><year>2019</year><volume>24</volume><fpage>101033</fpage><pub-id pub-id-type="doi">10.1016/j.siny.2019.101033</pub-id><pub-id pub-id-type="pmid">31607487</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Hooper SB, Roberts C, Dekker J, Te Pas AB (2019) Issues in cardiopulmonary transition at birth. Semin Fetal Neonatal Med 24:101033<pub-id pub-id-type="pmid">31607487</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.siny.2019.101033</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rios</surname><given-names>DR</given-names></name><name name-style="western"><surname>Martins</surname><given-names>FF</given-names></name><name name-style="western"><surname>El-Khuffash</surname><given-names>A</given-names></name><name name-style="western"><surname>Weisz</surname><given-names>DE</given-names></name><name name-style="western"><surname>Giesinger</surname><given-names>RE</given-names></name><name name-style="western"><surname>McNamara</surname><given-names>PJ</given-names></name></person-group><article-title>Early role of the atrial-level communication in premature infants with patent ductus arteriosus</article-title><source>J Am Soc Echocardiogr</source><year>2021</year><volume>34</volume><fpage>423</fpage><lpage>32.e421</lpage><pub-id pub-id-type="doi">10.1016/j.echo.2020.11.008</pub-id><pub-id pub-id-type="pmid">33227390</pub-id><pub-id pub-id-type="pmcid">PMC8026594</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Rios DR, Martins FF, El-Khuffash A, Weisz DE, Giesinger RE, McNamara PJ (2021) Early role of the atrial-level communication in premature infants with patent ductus arteriosus. J Am Soc Echocardiogr 34:423&#8211;32.e421<pub-id pub-id-type="pmid">33227390</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.echo.2020.11.008</pub-id><pub-id pub-id-type="pmcid">PMC8026594</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article></pmc-articleset>